BioMarin Pharmaceuticals
BMRN
BMRN
390 hedge funds and large institutions have $13.3B invested in BioMarin Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 161 increasing their positions, 121 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 388 → 390 (+2)
21% less capital invested
Capital invested by funds: $16.9B → $13.3B (-$3.59B)
Holders
390
Holding in Top 10
13
Calls
$119M
Puts
$84.2M
Top Buyers
| 1 | +$175M | |
| 2 | +$170M | |
| 3 | +$72.1M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$71M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$66M |
Top Sellers
| 1 | -$176M | |
| 2 | -$166M | |
| 3 | -$149M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$94.9M |
| 5 |
JPMorgan Chase & Co
New York
|
-$94.4M |